With a total investment of 1.7 billion yuan, four pharmaceutical projects are located in Yancheng Binhai.

Pharmaceutical Network Pharmaceutical Engineering" it is learned that recently held in 2020 Binhai Green Pharmaceutical Investment Development Conference, gathered from more than 90 pharmaceutical industry well-known enterprises, trade associations of more than 200 guestsA total of 4 pharmaceutical projects signed on-site, a total investment of 1.7 billion yuan, will promote the coastal pharmaceutical industry high-quality development into a new impetus, Zhang Hua, president of Shanghai Tsengno Pharmaceutical Group and chairman of Shanghai Disano Pharmaceutical Co., Ltd., said that it will invest about 1 billion yuan in Binhai, improve and upgrade the production system of anti-AIDS drugsraw materialsand build an annual output of 5 billion pieces of pharmaceutical industry park, anti-AIDS drugs as the core of the preparation of finished pharmaceutical projects, but also in the binhai construction of "national anti-HIV engineering technology research center"Emerging Inter-China Pharmaceutical Holdings Co., Ltdwill invest 5 billion yuan to set up a new inter-Sea Pharmaceutical Binhai subsidiary, and the coastal, park enterprises jointly set up a pharmaceutical industry development fund, the introduction of talent, technology, projects to Binhai to accelerate intelligent manufacturing upgrade, accelerate the formation of high-end parks and advantages with local characteristics of the industry, to help Binhai to build a whole industrial chain of biopharmaceuticalChina Resources Pharmaceutical Industry Fund will build a "listed company direct investment and fund investment" two-wheel drive, invest 5-7 billion yuan in Binhai new raw materials projects and anti-tumor, cardiovascular-type finished medicine projects, and constantly help Binhai tie-up, promote the transformation of results, promote innovation and entrepreneurship in the pharmaceutical industrypharmaceutical industry is one of the important sectors of the coastal construction of the "2 plus 2 plus 3" modern industrial systemIn recent years, Binhai focused on the pharmaceutical industry, has issued "on the further promotion of the chemical industry green transformation and development of the implementation of the opinion" "the county to promote the transformation and upgrading of the chemical industry to cultivate the development of the pharmaceutical industry" and 16 pharmaceutical industry investment policy ..Land acquisition project investment scale of more than 300 million yuan, investment intensity of 3 million yuan / mu, according to 5% of fixed asset investment to be rewarded;, Binhai Pharmaceutical Industrial Park is the province's pharmaceutical and chemical industry focus on the park, planning area of more than 20 square kilometers, planning pharmaceutical logistics, chemical agents, modern Chinese medicine, biological agents and medical equipment and other five functional areasIndustrial Park with "national bio-medicine incubator, the national torch Binhai new pharmaceutical industry base and the Chinese Academy of Sciences Shanghai Organic Institute green pharmaceutical industry research institute", to create a "green industrial park, beautiful medical dream" of the park brandPark has more than 40 pharmaceutical production enterprises, including state-owned enterprises, listed companies and other large-scale enterprises 30, the advantages of more than 100 kinds of raw materials and drugs, the concentration effect is obviousIt is reported that in recent years, Binhai Pharmaceutical Industrial Park to seize the development opportunities, high starting point planning park development, high standards to promote carrier construction, high-quality promotion of industrial agglomeration, focus on building the entire industrial chain, and actively build a high-quality development model of finished medicine, and achieved remarkable results Now, with the signing of these pharmaceutical projects, or will add new impetus to the rapid development of the coastal pharmaceutical industry.